Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
Fabien Zagnoli, A. Leblanc, Irina Viakhireva-Dovganyuk, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1463-1474
Open Access | Times Cited: 12

Showing 12 citing articles:

Terminal Care in Parkinson’s Disease: Real-Life Use of Continuous Subcutaneous Apomorphine Infusion to Improve Patient Comfort
Matthieu Béreau, Mathilde Giffard, Anne-Laure Clairet, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 1, pp. 209-219
Open Access | Times Cited: 6
Access to device-aided therapies in advanced Parkinson’s disease: navigating clinician biases, patient preference, and prognostic uncertainty
Manon Auffret, Daniel Weiß, Fabrizio Stocchi, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1411-1432
Open Access | Times Cited: 13
Apomorphine

Reactions Weekly (2025) Vol. 2051, Iss. 1, pp. 40-40
Closed Access
Influence of continuous subcutaneous apomorphine infusion on cognition and behavior in Parkinson's disease: A systematic review
Jean‐François Houvenaghel, Mylène Meyer, Emmanuelle Schmitt, et al.
Revue Neurologique (2024)
Closed Access | Times Cited: 2
Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson’s disease?
Zvezdan Pirtošek, Valentina Leta, Peter Jenner, et al.
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1395-1404
Closed Access | Times Cited: 4
Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice
Christopher Kobylecki, Lucy Partington-Smith
Journal of Neural Transmission (2023) Vol. 130, Iss. 11, pp. 1485-1489
Open Access | Times Cited: 2
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
Vinod Metta, Rajinder K. Dhamija, Lucia Batzu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Le prestataire de santé à domicile, un acteur méconnu dans la prise en charge du patient parkinsonien
Florian Poirier, Laura Sogni
Soins (2024) Vol. 69, Iss. 883, pp. 37-39
Closed Access
Integrating technology into a successful apomorphine delivery program in Thailand: a 10-year journey of achievements with a five-motto concept
Onanong Phokaewvarangkul, Nithinan Kantachadvanich, Vijittra Buranasrikul, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Apomorphine infusion in Parkinson's disease: An update
Teus van Laar, Harmen R. Moes, Regina Katzenschlager
International review of movement disorders (2024)
Closed Access
Maladie de Parkinson : traitements par dispositifs, stimulation dopaminergique continue
Marc Vérin, Manon Auffret
EMC - Neurologie (2024) Vol. 47, Iss. 4, pp. 1-11
Closed Access
La perfusion sous-cutanée d’apomorphine : recommandations à destination des acteurs de santé pour une installation à l’hôpital ou à domicile
Fabien Zagnoli, Marc Vérin, Astrid Tirel, et al.
Pratique Neurologique - FMC (2023) Vol. 14, Iss. 2, pp. 90-97
Open Access
Page 1

Scroll to top